Suppr超能文献

胰岛素抵抗与代谢综合征有关,而与冠状动脉疾病并无直接关联。

Insulin resistance is associated with the metabolic syndrome and is not directly linked to coronary artery disease.

机构信息

Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.

出版信息

Clin Chim Acta. 2011 May 12;412(11-12):1003-7. doi: 10.1016/j.cca.2011.02.008. Epub 2011 Feb 12.

Abstract

BACKGROUND

Insulin resistance (IR) is the key feature of the metabolic syndrome (MetS). Its association with directly visualized coronary atherosclerosis is unclear. We hypothesised that insulin resistance is associated with both angiographically determined coronary artery disease (CAD) and with the MetS.

METHODS

In 986 consecutive patients undergoing coronary angiography for the evaluation CAD, IR was determined by the HOMA index; the MetS was defined according to NCEP-ATPIII criteria; and significant CAD was diagnosed when coronary stenoses ≥50% were present.

RESULTS

HOMA IR scores were higher in MetS patients than in subjects without the MetS (4.9±6.4 vs. 2.2±2.0; p<0.001). HOMA IR did not differ significantly between patients with significant CAD and those who did not have significant CAD. When both, the presence of MetS and of significant CAD were considered, HOMA IR was significantly higher in patients with the MetS both among those who had significant CAD (4.9±6.8 vs. 2.2±1.8; p<0.001) and among those who did not have significant CAD (5.0±5.8 vs. 2.1±2.3; p<0.001), it did not differ significantly between patients with significant CAD and subjects without significant CAD among patients with the MetS nor among those without MetS. Similar results were obtained with the IDF definition of the MetS.

CONCLUSION

IR is significantly associated with the MetS but not with angiographically determined CAD. IR may play a greater role in the eventual precipitation of thrombosis than in the gradual progression of atherosclerosis.

摘要

背景

胰岛素抵抗(IR)是代谢综合征(MetS)的关键特征。其与直接观察到的冠状动脉粥样硬化的关系尚不清楚。我们假设胰岛素抵抗与血管造影确定的冠状动脉疾病(CAD)和 MetS 均相关。

方法

在 986 例连续行冠状动脉造影术评估 CAD 的患者中,通过 HOMA 指数确定 IR;根据 NCEP-ATPIII 标准定义 MetS;当冠状动脉狭窄≥50%时诊断为显著 CAD。

结果

MetS 患者的 HOMA IR 评分高于无 MetS 患者(4.9±6.4 vs. 2.2±2.0;p<0.001)。有显著 CAD 的患者与无显著 CAD 的患者之间,HOMA IR 没有显著差异。当同时考虑 MetS 和显著 CAD 的存在时,MetS 患者中同时具有显著 CAD(4.9±6.8 vs. 2.2±1.8;p<0.001)和不具有显著 CAD(5.0±5.8 vs. 2.1±2.3;p<0.001)的患者的 HOMA IR 明显更高,但在具有显著 CAD 的患者和不具有显著 CAD 的患者之间,MetS 患者中的 HOMA IR 没有显著差异,在无 MetS 患者中也是如此。用 IDF 对 MetS 的定义也得到了类似的结果。

结论

IR 与 MetS 显著相关,但与血管造影确定的 CAD 无关。IR 可能在血栓形成的最终发生中起更大的作用,而不是在动脉粥样硬化的逐渐进展中起作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验